Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation

2012 ◽  
Vol 18 (7) ◽  
pp. 779-785 ◽  
Author(s):  
Kenneth S. H. Chok ◽  
James Y. Y. Fung ◽  
See Ching Chan ◽  
Tan To Cheung ◽  
William W. Sharr ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Hepatorenal Syndrome ◽  
Donor Liver ◽  
Hepatic Decompensation ◽  
Donor Liver Transplantation ◽  
Type 1 Hepatorenal Syndrome

scholarly journals Hereditary Tyrosinemia Type 1 and Living Donor Liver Transplantation: Timing-Patient Selection-Complications

2021 ◽  
Vol 30 (2) ◽  
pp. 138-144
Author(s):  
Altan ALİM ◽  
Mehmet Burak DAL ◽  
Yalçın ERDOĞAN ◽  
Ertuğrul KIYKIM ◽  
Necdet GÜLER ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Patient Selection ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Tyrosinemia Type 1 ◽  
Hereditary Tyrosinemia

scholarly journals Patients with hepatorenal syndrome may have better renal outcome after living donor liver transplantation comparing with patients with chronic kidney disease

HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S343-S344
Author(s):  
Sheng-Chih Kuo ◽  
Yi-Chia Chan ◽  
Chih-Che Lin ◽  
Cheng-Hsi Yeh ◽  
Wei-Feng Li ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Liver Transplantation ◽  
Kidney Disease ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Hepatorenal Syndrome ◽  
Renal Outcome ◽  
Donor Liver ◽  
Donor Liver Transplantation

scholarly journals Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation

2009 ◽  
Vol 15 (6) ◽  
pp. 610-618 ◽  
Author(s):  
Aya Miyagawa-Hayashino ◽  
Hiroto Egawa ◽  
Tohru Yorifuji ◽  
Makoto Hasegawa ◽  
Hironori Haga ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Intrahepatic Cholestasis ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Progressive Familial Intrahepatic Cholestasis ◽  
Donor Liver Transplantation

Influence of hepatorenal syndrome on outcome of living donor liver transplantation: A single-center experience in 357 patients

2016 ◽  
Vol 47 (5) ◽  
pp. 425-434 ◽  
Author(s):  
Yusuke Okamura ◽  
Koichiro Hata ◽  
Osamu Inamoto ◽  
Toyonari Kubota ◽  
Hirofumi Hirao ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Hepatorenal Syndrome ◽  
Single Center ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Single Center Experience

scholarly journals Clinical outcomes of patients with hepatorenal syndrome after living donor liver transplantation

2012 ◽  
Vol 18 (10) ◽  
pp. 1237-1243 ◽  
Author(s):  
Jung Pyo Lee ◽  
Hyuk Yong Kwon ◽  
Ji In Park ◽  
Nam-Joon Yi ◽  
Kyung-Suk Suh ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Clinical Outcomes ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Hepatorenal Syndrome ◽  
Donor Liver ◽  
Donor Liver Transplantation

Adult-to-Adult Living-Donor Liver Transplantation

Swiss Surgery ◽  
2003 ◽  
Vol 9 (5) ◽  
pp. 227-236 ◽  
Author(s):  
Majno ◽  
Mentha ◽  
Berney ◽  
Bühler ◽  
Giostra ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Therapeutic Option ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Multidisciplinary Program ◽  
First Case ◽  
Living Donor Transplantation ◽  
The Right

Living donor liver transplantation is a relatively new procedure in which the right side of the liver is harvested in a healthy donor and transplanted into a recipient. After the first case in 1994, over 3000 cases have been done worldwide. This review summarizes the reasons why the procedure is needed, describes its main technical aspects, highlights the boundaries in which it can be done safely, summarizes the current experience worldwide and describes the main points of the program in our unit. We argue that living-donor transplantation is a viable alternative to a long time on the waiting list for several patients, and it can be performed safely and successfully provided that all precautions are undertaken to minimize the risks in the donor and to increase the chances of a good outcome in the recipients. If these prerequisites are met, and within the framework of a structured multidisciplinary program, we believe that living-donor liver transplantation should be funded by health insurances as a recognized therapeutic option.

Sign in / Sign up

Export Citation Format

Share Document